Pages that link to "Q43102398"
Jump to navigation
Jump to search
The following pages link to Exploratory study on the reversal of warfarin with rFVIIa in healthy subjects (Q43102398):
Displaying 27 items.
- Nonvitamin K antagonist oral anticoagulant activity: challenges in measurement and reversal (Q28071657) (← links)
- Guidelines on oral anticoagulation with warfarin – fourth edition (Q28240666) (← links)
- Potential applications of thromboelastography in patients with acute and chronic liver disease (Q33405129) (← links)
- Anticoagulation reversal in the era of the non-vitamin K oral anticoagulants (Q34469002) (← links)
- Thromboembolic risks of recombinant factor VIIa Use in warfarin-associated intracranial hemorrhage: a case-control study (Q34513276) (← links)
- Global assays and the management of oral anticoagulation (Q35164902) (← links)
- Therapeutic strategies in acute intracerebral hemorrhage (Q35729599) (← links)
- How I treat warfarin-associated coagulopathy in patients with intracerebral hemorrhage (Q37853763) (← links)
- Challenges and controversies in the medical management of primary and antithrombotic-related intracerebral hemorrhage (Q37978627) (← links)
- Reversal of antithrombotic agents (Q37998377) (← links)
- Reversal of drug-induced anticoagulation: old solutions and new problems (Q38009420) (← links)
- Medical versus surgical management of intracerebral hematomas (Q38018892) (← links)
- Emergency management of bleeding associated with old and new oral anticoagulants. (Q38027479) (← links)
- Intracerebral hemorrhage: a review of coagulation function. (Q38035818) (← links)
- Reversal of target-specific oral anticoagulants (Q38105270) (← links)
- Who, when, and how to reverse non-vitamin K oral anticoagulants (Q38655960) (← links)
- Comparison of 3-Factor Prothrombin Complex Concentrate and Low-Dose Recombinant Factor VIIa for Warfarin Reversal (Q38911940) (← links)
- Timing of INR reversal using fresh-frozen plasma in warfarin-associated intracerebral hemorrhage. (Q40475411) (← links)
- Three or four factor prothrombin complex concentrate for emergency anticoagulation reversal? (Q42735619) (← links)
- Rethinking warfarin reversal (Q42944939) (← links)
- Left ventricular assist device-induced coagulation and platelet activation and effect of the current anticoagulant therapy regimen (Q44929986) (← links)
- Safety and pharmacokinetics of a recombinant fusion protein linking coagulation factor VIIa with albumin in healthy volunteers (Q45857094) (← links)
- Rivaroxaban reversal with prothrombin complex concentrate or tranexamic acid in healthy volunteers (Q50142273) (← links)
- Prothrombin Complex Concentrates for Perioperative Vitamin K Antagonist and Non-vitamin K Anticoagulant Reversal (Q60568634) (← links)
- Factor VIIa administration in traumatic brain injury: an AAST-MITC propensity score analysis (Q88687080) (← links)
- European Stroke Organisation Guideline on Reversal of Oral Anticoagulants in Acute Intracerebral Haemorrhage (Q92426236) (← links)
- Calibrated Automated Thrombinography (CAT), a Tool to Identify Patients at Risk of Bleeding during Anticoagulant Therapy: A Systematic Review (Q93092195) (← links)